September 27, 2000Carbamazepine Tablets Recalled
public notice issued by FDA of 'completed recall'...
IN (SafetyAlerts) - The Food and
Drug Administration (FDA) has announced that Pharmaceutical Corporation of America is
recalling its Carbamazepine Tablets, 200 mg, Rx because of a label mix-up - A portion of
the lot was labeled as tetracycline 500 mg.
This is the first public notice of
this Class II
recall issued by FDA.
Carbamazepine Tablets, 200 mg, Rx. NDC #51655-428-26.
Lot #S302QJ EXP 10/31/01.
Pharmaceutical Corporation of America, Carmel, Indiana.
Repacker, by notifying the V.A. to return the goods on November 24, 1999. Firm-initiated
**Completed recall: While the FDA has completed
processing of this particular recall, it does not mean this particular product has been
fully accounted for.
4,532 bottles were distributed; firm estimates none remains on the market.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.